Mike is pursuing his J.D. at Boston College Law School. During his first year at BC, Mike wrote an article for the Boston College Intellectual Property and Technology Forum, focusing on the patent interference proceeding and dispute over patent rights to the recently discovered genetic engineering technology CRISPR-Cas9. He will be serving as an Editor for the Forum in the upcoming school year. While pursuing a degree in Biology, Mike worked as a research assistant on multiple projects, including a study within the Department of Pharmacology at Yale Medical School focused on understanding the biochemical mechanisms underlying the development and progression of the neurodegenerative disease Spinocerebellar Ataxia-13.
Recently, WHIPGROUP engaged in an arbitration that included a five day hearing in the City. Here are some thoughts about why arbitration is different (not clearly better or worse) than litigation. Venue The AAA arbitral [Read More…]
WHIPGroup previously filed a Motion to Dismiss a patent infringement suit filed against its client TomTom in the Western District of Texas. Rather than opposing WHIPGroup’s motion to dismiss, Plaintiff MDSP Technologies LLC voluntarily dismissed [Read More…]
WHIPgroup succeeded in having anticipation and indefiniteness rejections overturned by the Patent Trial and Appeal Board (PTAB). The claimed invention relates to a sequencing station that manages both sequencing and restacking tasks. The Examiner had [Read More…]